UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 97

Sortiert nach

Prednisolone or Pentoxifylline for Alcoholic Hepatitis

The New England journal of medicine, 2015-04, Vol.372 (17), p.1619-1628

2015

Link zum Volltext

Verfügbarkeit prüfen

Mental Imagery to Reduce Alcohol-related harm in patients with alcohol dependence and alcohol-related liver damaGE: the MIRAGE pilot trial protocol

BMJ open, 2022-05, Vol.12 (5), p.e060498-e060498

2022

Link zum Volltext

Verfügbarkeit prüfen

Mental Imagery to Reduce Alcohol-related harm in patients with alcohol use disorder and alcohol-related liver damaGE: the MIRAGE randomised pilot trial results

BMJ open gastroenterology, 2024-01, Vol.11 (1), p.e001267

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical and microbiological features of infection in alcoholic hepatitis: an international cohort study

Journal of gastroenterology, 2017-11, Vol.52 (11), p.1192-1200

2017

Link zum Volltext

Verfügbarkeit prüfen

The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial

Health technology assessment (Winchester, England), 2015-12, Vol.19 (102), p.1-104

2015

Link zum Volltext

Verfügbarkeit prüfen

Molecular targets in the treatment of alcoholic hepatitis

World journal of gastroenterology : WJG, 2012-10, Vol.18 (39), p.5504-5513

2012

Link zum Volltext

Verfügbarkeit prüfen

Trajectory of Serum Bilirubin Predicts Spontaneous Recovery in a Real-World Cohort of Patients With Alcoholic Hepatitis

Clinical gastroenterology and hepatology, 2022-02, Vol.20 (2), p.e289-e297

2022

Link zum Volltext

Verfügbarkeit prüfen

Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis

Journal of hepatology, 2018-03, Vol.68 (3), p.511-518

2018

Link zum Volltext

Verfügbarkeit prüfen

Hereditary haemochromatosis: only 1% of adult HFE C282Y homozygotes in South Wales have a clinical diagnosis of iron overload

Human genetics, 2002-12, Vol.111 (6), p.538-543

2002

Link zum Volltext

Verfügbarkeit prüfen

Sex, Drugs, and “Heavy Metal”: Does Diet Also Matter in the Clinical Expression of Hereditary Hemochromatosis?

Mayo Clinic proceedings, 2008-05, Vol.83 (5), p.526-528

McCune, C. Anne, MBBS, MD

2008

Link zum Volltext

Verfügbarkeit prüfen

Is liver biopsy necessary in the management of alcoholic hepatitis?

World journal of gastroenterology : WJG, 2013-11, Vol.19 (44), p.7825-7829

2013

Link zum Volltext

Verfügbarkeit prüfen

In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, Associated With High Circulating Levels of Bacterial DNA

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.1068-1077.e4

2017

Link zum Volltext

Verfügbarkeit prüfen

SAT-285-YI Incorporation of cholestasis into prognostic models improves predictive outcome in alcohol-related liver disease: a retrospective multicenter study

Journal of hepatology, 2024-06, Vol.80, p.S148-S149

2024

Link zum Volltext

Verfügbarkeit prüfen

SAT-280 Emergence of co-morbidities in alcohol-related hepatitis over time: insights from the WALDO cohort

Journal of hepatology, 2024-06, Vol.80, p.S147-S147

2024

Link zum Volltext

Verfügbarkeit prüfen

Inequity in end-of-life care for patients with chronic liver disease in England

Liver international, 2023-11, Vol.43 (11), p.2393-2403

2023

Link zum Volltext

Verfügbarkeit prüfen

alfapump System vs. Large Volume Paracentesis for Refractory Ascites: A Multicenter Randomized Controlled Study

Journal of hepatology, 2017-11, Vol.67 (5), p.940-949

2017

Link zum Volltext

Verfügbarkeit prüfen

Strategies are needed to support people with alcohol use disorder and alcohol-related liver disease to take part in randomised clinical trials: results from the MIRAGE pilot trial of functional imagery training

Journal of hepatology, 2023-06, Vol.78, p.S153-S154

2023

Link zum Volltext

Verfügbarkeit prüfen

FRI-418 - Strategies are needed to support people with alcohol use disorder and alcohol-related liver disease to take part in randomised clinical trials: results from the MIRAGE pilot trial of functional imagery training

Journal of hepatology, 2023-06, Vol.78, p.S153-S154

2023

Link zum Volltext

Verfügbarkeit prüfen

Diabetes increases risk of mortality in alcohol-related liver disease

Journal of hepatology, 2023-06, Vol.78, p.S157-S158

2023

Link zum Volltext

Verfügbarkeit prüfen

FRI-422 - Diabetes increases risk of mortality in alcohol-related liver disease

Journal of hepatology, 2023-06, Vol.78, p.S157-S158

2023

Link zum Volltext

Verfügbarkeit prüfen

NI‐0801, an anti‐chemokine (C‐X‐C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid

Hepatology communications, 2018-05, Vol.2 (5), p.492-503

2018

Link zum Volltext

Verfügbarkeit prüfen

Refining the natural history of alcohol related liver disease: a competing risk analysis

Journal of hepatology, 2022-07, Vol.77, p.S141

2022

Link zum Volltext

Verfügbarkeit prüfen

Integration of palliative and supportive care in the management of advanced liver disease: development and evaluation of a prognostic screening tool and supportive care intervention

Frontline gastroenterology, 2017-01, Vol.8 (1), p.45-52

2017

Link zum Volltext

Verfügbarkeit prüfen

Long‐term outcome in patients with severe alcoholic hepatitis can be reliably determined using an in vitro measure of steroid sensitivity

Hepatology (Baltimore, Md.), 2015-03, Vol.61 (3), p.1099-1099

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(97)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Prednisolone or Pentoxifylline for Alcoholic Hepatitis

Mental Imagery to Reduce Alcohol-related harm in patients with alcohol dependence and alcohol-related liver damaGE: the MIRAGE pilot trial protocol

Mental Imagery to Reduce Alcohol-related harm in patients with alcohol use disorder and alcohol-related liver damaGE: the MIRAGE randomised pilot trial results

Clinical and microbiological features of infection in alcoholic hepatitis: an international cohort study

The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial

Molecular targets in the treatment of alcoholic hepatitis

Trajectory of Serum Bilirubin Predicts Spontaneous Recovery in a Real-World Cohort of Patients With Alcoholic Hepatitis

Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis

Hereditary haemochromatosis: only 1% of adult HFE C282Y homozygotes in South Wales have a clinical diagnosis of iron overload

Sex, Drugs, and “Heavy Metal”: Does Diet Also Matter in the Clinical Expression of Hereditary Hemochromatosis?

Is liver biopsy necessary in the management of alcoholic hepatitis?

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, Associated With High Circulating Levels of Bacterial DNA

SAT-285-YI Incorporation of cholestasis into prognostic models improves predictive outcome in alcohol-related liver disease: a retrospective multicenter study

SAT-280 Emergence of co-morbidities in alcohol-related hepatitis over time: insights from the WALDO cohort

Inequity in end-of-life care for patients with chronic liver disease in England

alfapump System vs. Large Volume Paracentesis for Refractory Ascites: A Multicenter Randomized Controlled Study

Strategies are needed to support people with alcohol use disorder and alcohol-related liver disease to take part in randomised clinical trials: results from the MIRAGE pilot trial of functional imagery training

FRI-418 - Strategies are needed to support people with alcohol use disorder and alcohol-related liver disease to take part in randomised clinical trials: results from the MIRAGE pilot trial of functional imagery training

Diabetes increases risk of mortality in alcohol-related liver disease

FRI-422 - Diabetes increases risk of mortality in alcohol-related liver disease

NI‐0801, an anti‐chemokine (C‐X‐C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid

Refining the natural history of alcohol related liver disease: a competing risk analysis

Integration of palliative and supportive care in the management of advanced liver disease: development and evaluation of a prognostic screening tool and supportive care intervention

Long‐term outcome in patients with severe alcoholic hepatitis can be reliably determined using an in vitro measure of steroid sensitivity

Suchergebnisse filtern